Ausgabe 6/2014
Inhalt (30 Artikel)
Prognostic value of 18F-DOPA PET/CT at the time of recurrence in patients affected by neuroblastoma
Arnoldo Piccardo, Matteo Puntoni, Egesta Lopci, Massimo Conte, Luca Foppiani, Stefania Sorrentino, Giovanni Morana, Mehrdad Naseri, Angelina Cistaro, Giampiero Villavecchia, Stefano Fanti, Alberto Garaventa
FDG PET during radiochemotherapy is predictive of outcome at 1 year in non-small-cell lung cancer patients: a prospective multicentre study (RTEP2)
Pierre Vera, Sandrine Mezzani-Saillard, Agathe Edet-Sanson, Jean-François Ménard, Romain Modzelewski, Sebastien Thureau, Marc-Etienne Meyer, Khadija Jalali, Stéphane Bardet, Delphine Lerouge, Claire Houzard, Françoise Mornex, Pierre Olivier, Guillaume Faure, Caroline Rousseau, Marc-André Mahé, Philippe Gomez, Isabelle Brenot-Rossi, Naji Salem, Bernard Dubray
PET/MRI and PET/CT in follow-up of head and neck cancer patients
Marcelo A. Queiroz, Martin Hüllner, Felix Kuhn, Gerhardt Huber, Christian Meerwein, Spyros Kollias, Gustav von Schulthess, Patrick Veit-Haibach
Prognostic relevance of 18F-FDG PET uptake in patients with locally advanced, extremity soft tissue sarcomas undergoing neoadjuvant isolated limb perfusion with TNF-α and melphalan
Dimosthenis Andreou, Henrike Boldt, Daniel Pink, Björn Jobke, Mathias Werner, Markus Schuler, Peter Reichardt, Per-Ulf Tunn
Diagnostic accuracy of 18F-FDG PET/CT for detection of suspected recurrence in patients with oesophageal carcinoma
Punit Sharma, Sachin Jain, Sellam Karunanithi, Sujoy Pal, Pramod Kumar Julka, Sanjay Thulkar, Arun Malhotra, Chandrasekhar Bal, Rakesh Kumar
Metabolic tumour burden assessed by 18F-FDG PET/CT associated with serum CA19-9 predicts pancreatic cancer outcome after resection
Hua-Xiang Xu, Tao Chen, Wen-Quan Wang, Chun-Tao Wu, Chen Liu, Jiang Long, Jin Xu, Ying-Jian Zhang, Run-Hao Chen, Liang Liu, Xian-Jun Yu
Staging the axilla in breast cancer patients with 18F-FDG PET: how small are the metastases that we can detect with new generation clinical PET systems?
Dimitri Bellevre, Cécile Blanc Fournier, Odile Switsers, Audrey Emmanuelle Dugué, Christelle Levy, Djelila Allouache, Cédric Desmonts, Hubert Crouet, Jean-Marc Guilloit, Jean-Michel Grellard, Nicolas Aide
Metabolic tumour volumes measured at staging in lymphoma: methodological evaluation on phantom experiments and patients
Michel Meignan, Myriam Sasanelli, René Olivier Casasnovas, Stefano Luminari, Federica Fioroni, Chiara Coriani, Helene Masset, Emmanuel Itti, Paolo G. Gobbi, Francesco Merli, Annibale Versari
Factors affecting intrapatient liver and mediastinal blood pool 18F-FDG standardized uptake value changes during ABVD chemotherapy in Hodgkin’s lymphoma
Agostino Chiaravalloti, Roberta Danieli, Paolo Abbatiello, Barbara Di Pietro, Laura Travascio, Maria Cantonetti, Manlio Guazzaroni, Antonio Orlacchio, Giovanni Simonetti, Orazio Schillaci
Characterizing bone marrow involvement in Hodgkin’s lymphoma by FDG-PET/CT
Michal Weiler-Sagie, Olga Kagna, Eldad J. Dann, Ayelet Ben-Barak, Ora Israel
Individualized dosimetry-based activity reduction of 90Y-DOTATOC prevents severe and rapid kidney function deterioration from peptide receptor radionuclide therapy
Sofie Van Binnebeek, Kristof Baete, Bert Vanbilloen, Christelle Terwinghe, Michel Koole, Felix M. Mottaghy, Paul M. Clement, Luc Mortelmans, Karin Haustermans, Eric Van Cutsem, Alfons Verbruggen, Kris Bogaerts, Chris Verslype, Christophe M. Deroose
Twins in spirit part II: DOTATATE and high-affinity DOTATATE—the clinical experience
Claudia Brogsitter, Klaus Zöphel, Holger Hartmann, Margret Schottelius, Hans-Jürgen Wester, Jörg Kotzerke
Radiolabelled GLP-1 receptor antagonist binds to GLP-1 receptor-expressing human tissues
Beatrice Waser, Jean Claude Reubi
PET/MR attenuation correction: where have we come from and where are we going?
Dimitris Visvikis, Florian Monnier, Julien Bert, Mathieu Hatt, Hadi Fayad
A comparison of CT- and MR-based attenuation correction in neurological PET
John C. Dickson, Celia O’Meara, Anna Barnes
The effect of amyloid pathology and glucose metabolism on cortical volume loss over time in Alzheimer’s disease
Sofie M. Adriaanse, Koene R. A. van Dijk, Rik Ossenkoppele, Martin Reuter, Nelleke Tolboom, Marissa D. Zwan, Maqsood Yaqub, Ronald Boellaard, Albert D. Windhorst, Wiesje M. van der Flier, Philip Scheltens, Adriaan A. Lammertsma, Frederik Barkhof, Bart N. M. van Berckel
18F-FLT and 18F-FDOPA PET kinetics in recurrent brain tumors
Mirwais Wardak, Christiaan Schiepers, Timothy F. Cloughesy, Magnus Dahlbom, Michael E. Phelps, Sung-Cheng Huang
Cross sectional PET study of cerebral adenosine A1 receptors in premanifest and manifest Huntington’s disease
Andreas Matusch, Carsten Saft, David Elmenhorst, Peter H. Kraus, Ralf Gold, Hans-Peter Hartung, Andreas Bauer
Impact of right-ventricular apical pacing on the optimal left-ventricular lead positions measured by phase analysis of SPECT myocardial perfusion imaging
Guang-Uei Hung, Jin-Long Huang, Wan-Yu Lin, Shih-Chung Tsai, Kuo-Yang Wang, Shih-Ann Chen, Michael S. Lloyd, Ji Chen
Sites of latest mechanical activation as assessed by SPECT myocardial perfusion imaging in ischemic and dilated cardiomyopathy patients with LBBB
Xianhe Lin, Huiqin Xu, Xuefeng Zhao, Ji Chen
Attenuated right ventricular energetics evaluated using 11C-acetate PET in patients with pulmonary hypertension
Keiichiro Yoshinaga, Hiroshi Ohira, Ichizo Tsujino, Noriko Oyama-Manabe, Lisa Mielniczuk, Rob S. B. Beanlands, Chietsugu Katoh, Katsuhiko Kasai, Osamu Manabe, Takahiro Sato, Satoshi Fujii, Yoichi M. Ito, Yuuki Tomiyama, Masaharu Nishimura, Nagara Tamaki
Authorship problems in scientific literature and in nuclear medicine: the point of view of the young researcher
Salvatore Annunziata, Alessandro Giordano
Radiolabelled apoptotic probe may be a vehicle for a novel multimodality radionuclide tumour therapy
S. Dizdarevic, R. McCready, J. F. C. Turner, M. C. Bagley, P. Blower, P. Schmid, G. Flux, A. Hall, I. Ziv
Comment on: The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer
Carlo Aprile, Federica E. Buroni, Lorenzo Lodola, Marco G. Persico
Response to comment by Aprile et al.: The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer
F. Giammarile, N. Alazraki, J. N. Aarsvold, R. A. Audisio, E. Glass, S. F. Grant, J. Kunikowska, M. Leidenius, V. M. Moncayo, R. F. Uren, W. J. Oyen, R. A. Valdés Olmos, S. Vidal Sicart
Paul S. Sidhu, Suzanne M. Ryan, Phillip F.C. Lung (Eds): FRCR 2B Viva: A Case-based Approach
Valentina Piscopo, Luigi Mansi
Ignasi Carrio and Pablo Ros (Eds.): PET/MRI Methodology and Clinical Applications
Luigi Mansi
FDG PET/CT in autoimmune pancreatitis
Cristina Nanni, Rossella Romagnoli, Ilaria Rambaldi, Paola Caroli, Federica Matteucci, Valentina Ambrosini, Giuseppe Re, Stefano Fanti